Literature DB >> 22781934

Uterine distension differentially affects remodelling and distensibility of the uterine vasculature in non-pregnant rats.

George Osol1, Carolyn Barron, Maurizio Mandalà.   

Abstract

During pregnancy the mammalian uterine circulation undergoes significant expansive remodelling necessary for normal pregnancy outcome. The underlying mechanisms are poorly defined. The goal of this study was to test the hypothesis that myometrial stretch actively stimulates uterine vascular remodelling by developing a new surgical approach to induce unilateral uterine distension in non-pregnant rats. Three weeks after surgery, which consisted of an infusion of medical-grade silicone into the uterine lumen, main and mesometrial uterine artery and vein length, diameter and distensibility were recorded. Radial artery diameter, distensibility and vascular smooth muscle mitotic rate (Ki67 staining) were also measured. Unilateral uterine distension resulted in significant increases in the length of main uterine artery and vein and mesometrial segments but had no effect on vessel diameter or distensibility. In contrast, there were significant increases in the diameter of the radial arteries associated with the distended uterus. These changes were accompanied by reduced arterial distensibility and increased vascular muscle hyperplasia. In summary, this is the first report to show that myometrial stretch is a sufficient stimulus to induce significant remodelling of uterine vessels in non-pregnant rats. Moreover, the results indicate differential regulation of these growth processes as a function of vessel size and type.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22781934     DOI: 10.1071/RD11208

Source DB:  PubMed          Journal:  Reprod Fertil Dev        ISSN: 1031-3613            Impact factor:   2.311


  3 in total

1.  Uterine microvascular sensitivity to nanomaterial inhalation: An in vivo assessment.

Authors:  P A Stapleton; C R McBride; J Yi; T R Nurkiewicz
Journal:  Toxicol Appl Pharmacol       Date:  2015-09-14       Impact factor: 4.219

Review 2.  Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function.

Authors:  Hamutal Meiri; George Osol; Irene Cetin; Sveinbjörn Gizurarson; Berthold Huppertz
Journal:  Comput Struct Biotechnol J       Date:  2017-09-22       Impact factor: 7.271

Review 3.  Developmental onset of cardiovascular disease-Could the proof be in the placenta?

Authors:  Jeanine N D'Errico; Phoebe A Stapleton
Journal:  Microcirculation       Date:  2019-01-23       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.